Journal article

Noninvasive prenatal testing for fetal aneuploidy and single gene disorders

Hannah Skrzypek, Lisa Hui

Best Practice & Research Clinical Obstetrics & Gynaecology | ELSEVIER SCI LTD | Published : 2017


Our concept of nucleic acid biology has advanced dramatically over the past two decades, with a growing appreciation that cell-free DNA (cfDNA) fragments are present in all body fluids including plasma. In no other field has plasma DNA been as rapidly translated into clinical practice as in noninvasive prenatal testing (NIPT) for fetal chromosome abnormalities. NIPT is a screening test that requires confirmation with diagnostic testing, but other applications of cfDNA provide diagnostic information and do not require invasive testing. These applications are referred to as noninvasive prenatal diagnosis (NIPD) and include determination of fetal sex, blood group and some single gene disorders...

View full abstract